Pierre Fabre Medicament Osteogenon 830mg Tablets (10×4)
Overview
Osteogenon is a 830 mg tablet formulated to support bone and joint health. Each tablet contains an ossine‑hydroxyapatite complex, a bioactive compound derived from hydroxyapatite that is naturally found in bone tissue.
Manufactured by Pierre Fabre Medicament Production in France, the product is packaged in four separate blister packs, each holding ten tablets. The packaging is designed for convenient daily use and easy storage.
Why You'll Like It
- High‑dose 830 mg tablets for robust support
- Bioactive ossine‑hydroxyapatite complex for bone health
- Trusted French pharmaceutical manufacturing
- Convenient 10‑tablet blister packs for daily routine
- Clear labeling and dosage information
Who It's For
- Adults seeking bone and joint support
- Individuals looking for a daily supplement to maintain skeletal health
- Those who prefer a well‑documented, pharmaceutical‑grade product
Package Details
4 blister packs, 10 tablets each (total 40 tablets). Each tablet is 830 mg and contains an ossine‑hydroxyapatite complex.
Common Questions
What is the dosage per tablet?
– Each tablet contains 830 mg of the active complex.
How many tablets are in each pack?
– Each blister pack contains 10 tablets.
Is this product manufactured in France?
– Yes, it is produced by Pierre Fabre Medicament Production in France.
Related shopping options
Explore related products by family, manufacturer or listed ingredient. Shared ingredients do not mean products are interchangeable; check strength, form and label information.
Related category
Belmedpreparaty Hawthorn-Belmed tincture, 50 ml.
Related category
Grindex Mildronate, 250 mg, 40 caps.
Related category
Servier Detralex, 1000 mg, 30 tab.
Related category
Ternofarm Eskuven-Ternofarm gel, 1%, 50 g.
Related category
Pharmaceutical technology Troxovazole gel, 20 mg / g, 50 g.
Related category